Innovita Biological Technology Co. Ltd. A (688253) — Cash Flow Reinvestment Rate
Innovita Biological Technology Co. Ltd. A (688253) has a Cash Flow Reinvestment Rate of 1.21x as of December 2025, reinvesting CN¥234.32 Million (capex CN¥31.13 Million plus investments CN¥203.19 Million) from operating cash flow of CN¥193.13 Million. See Innovita Biological Technology Co. Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Innovita Biological Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Innovita Biological Technology Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see 688253 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for Innovita Biological Technology Co. Ltd. A. See 688253 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.21x | CN¥234.32 Million | CN¥193.13 Million | CN¥31.13 Million | ▲ +495.2% |
| 2024 | 0.20x | CN¥62.26 Million | CN¥305.46 Million | CN¥36.16 Million | ▼ -88.1% |
| 2023 | 1.72x | CN¥445.88 Million | CN¥259.85 Million | CN¥16.97 Million | ▼ -81.0% |
| 2022 | 9.05x | CN¥1.14 Billion | CN¥126.43 Million | CN¥57.71 Million | ▲ +833.1% |
| 2021 | 0.97x | CN¥103.02 Million | CN¥106.27 Million | CN¥63.75 Million | ▲ +173.0% |
| 2020 | 0.36x | CN¥227.16 Million | CN¥639.82 Million | CN¥76.71 Million | — |